![Martin Ostrowski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martin Ostrowski
Chief Tech/Sci/R&D Officer at Ryne Biotechnology, Inc.
Martin Ostrowski active positions
Companies | Position | Start | End |
---|---|---|---|
Saisei Ventures LLC
![]() Saisei Ventures LLC Investment ManagersFinance Saisei Ventures LLC (Saisei Ventures) is a venture capital firm founded by Jonathan Yeh in 2020. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 2022-12-31 | - |
Ryne Biotechnology, Inc.
![]() Ryne Biotechnology, Inc. BiotechnologyHealth Technology Ryne Biotechnology, Inc. is an American US-based biotechnology company that focuses on developing next-generation approaches to cure neurological disorders. The company utilizes induced pluripotent stem cell (iPSC) technology to advance its off-the-shelf neuron replacement therapeutics. Ryne Bio is dedicated to advancing a pipeline targeting neurological diseases by focusing on an iPSC technology platform and forging partnerships with leaders in surgical delivery and clinical development. | Chief Tech/Sci/R&D Officer | 2022-02-28 | - |
Career history of Martin Ostrowski
Former positions of Martin Ostrowski
Companies | Position | Start | End |
---|---|---|---|
Dianomi Therapeutics, Inc.
![]() Dianomi Therapeutics, Inc. BiotechnologyHealth Technology Dianomi Therapeutics, Inc. engages in the development of Mineral Coated Microparticle (MCM) technology. It focuses on the improvement of drug molecules for targeting autoimmune diseases. The company was founded by Barry Kurokawa, William Murphy, Martin Ostrowski, and Anna Clements in 2017 and is headquartered in Madison, WI. | Chief Operating Officer | 2019-01-31 | 2022-07-30 |
Founder | 2019-01-31 | 2020-07-30 | |
President | 2020-07-31 | 2022-07-30 | |
Vascugen, Inc.
![]() Vascugen, Inc. BiotechnologyHealth Technology Vascugen, Inc. provides biotechnology services. The company is headquartered in Madison, WI. | Chief Tech/Sci/R&D Officer | 2017-05-31 | 2019-11-29 |
Founder | 2017-05-31 | 2019-11-29 | |
mRNA RiboTherapeutics, Inc.
![]() mRNA RiboTherapeutics, Inc. BiotechnologyHealth Technology mRNA RiboTherapeutics, Inc. provides products and technology for making and using ribonucleic acid for translation in cells for clinical research and therapeutics. It offers products for MRNA production in vitro transcription, post-transcriptional capping, co--transcriptional capping, post-transcriptional tailing, modified NTP in vitro transcription, mRNA decapping, and RNase inhibition. The company is headquartered in Madison, WI. | Director/Board Member | 2010-12-31 | 2019-01-01 |
Training of Martin Ostrowski
Case Western Reserve University School of Medicine | Graduate Degree |
Case Western Reserve University School of Law | Graduate Degree |
Statistics
International
United States | 8 |
Operational
Founder | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Graduate Degree | 2 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 5 |
---|---|
Dianomi Therapeutics, Inc.
![]() Dianomi Therapeutics, Inc. BiotechnologyHealth Technology Dianomi Therapeutics, Inc. engages in the development of Mineral Coated Microparticle (MCM) technology. It focuses on the improvement of drug molecules for targeting autoimmune diseases. The company was founded by Barry Kurokawa, William Murphy, Martin Ostrowski, and Anna Clements in 2017 and is headquartered in Madison, WI. | Health Technology |
Saisei Ventures LLC
![]() Saisei Ventures LLC Investment ManagersFinance Saisei Ventures LLC (Saisei Ventures) is a venture capital firm founded by Jonathan Yeh in 2020. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Ryne Biotechnology, Inc.
![]() Ryne Biotechnology, Inc. BiotechnologyHealth Technology Ryne Biotechnology, Inc. is an American US-based biotechnology company that focuses on developing next-generation approaches to cure neurological disorders. The company utilizes induced pluripotent stem cell (iPSC) technology to advance its off-the-shelf neuron replacement therapeutics. Ryne Bio is dedicated to advancing a pipeline targeting neurological diseases by focusing on an iPSC technology platform and forging partnerships with leaders in surgical delivery and clinical development. | Health Technology |
Vascugen, Inc.
![]() Vascugen, Inc. BiotechnologyHealth Technology Vascugen, Inc. provides biotechnology services. The company is headquartered in Madison, WI. | Health Technology |
mRNA RiboTherapeutics, Inc.
![]() mRNA RiboTherapeutics, Inc. BiotechnologyHealth Technology mRNA RiboTherapeutics, Inc. provides products and technology for making and using ribonucleic acid for translation in cells for clinical research and therapeutics. It offers products for MRNA production in vitro transcription, post-transcriptional capping, co--transcriptional capping, post-transcriptional tailing, modified NTP in vitro transcription, mRNA decapping, and RNase inhibition. The company is headquartered in Madison, WI. | Health Technology |
- Stock Market
- Insiders
- Martin Ostrowski
- Experience